Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Nuffield Department of Orthopaedic, Rheumatology and Musculoskeletal Sciences (NDORMS) is delighted to announce that Professor Jonathan Rees has been appointed as the new Director of the Botnar Research Institute

Horizontal portrait of Jonathan Rees

Professor Rees will take up the role in August 2021 from Professor Andrew Carr, also the Head of Department at NDORMS, who said: “Prof Jonny Rees is an outstanding clinician scientist with a strong track record in research that has positively influenced the care of patients with musculoskeletal disorders. His vision and energy will be of enormous value as the new Marcela wing of the Botnar opens and we expand our research and teaching programmes.” 

Prof Rees graduated from St Mary's Hospital Medical School, London, then trained in orthopaedics in Oxford. He was appointed Clinical Lecturer to NDORMS in 2004 and then University Lecturer in 2005. He continued as a shoulder and elbow surgeon, while teaching, training and running a musculoskeletal research programme before becoming Professor of Orthopaedic Surgery and Musculoskeletal Science in 2014. He is the incoming President of the British Elbow and Shoulder Society, and has recently been selected to be an NIHR Senior Investigator. Besides his university and national work, he continues to work as a Consultant Orthopaedic Shoulder Surgeon at the Nuffield Orthopaedic Centre (NOC). 

“I am thrilled to be taking over the Directorship of the Botnar at such an exciting time,” said Prof Rees. “Exciting because the new Marcela wing of the Botnar is nearing completion, and exciting because we seem to be exiting the pandemic and I will be able to welcome all our staff and students back to the Institute. The last 12 years under the Directorship of Andy Carr has seen a step change in musculoskeletal research capacity at the Botnar and I look forward to working with all our brilliant staff to make the next decade even more successful.” 

Similar stories

AI helps to detect bone fractures to 92% accuracy

Research from the Botnar Institute for Musculoskeletal Sciences shows that Artificial intelligence (AI) is an effective tool for fracture detection that has potential to aid clinicians in busy emergency departments.

Oxford leads global cross-collaboration Covid research

A new collaboration between Oxford, Brazil and Pakistan has been funded by the Bill & Melinda Gates Foundation. The partnership will provide researchers with de-identified health data from two of the worlds global COVID-19 hotspots to increase understanding of COVID-19 in these communities and help accelerate the management of the disease.

Study reveals that bone changes the energy requirements of cancer cells to promote growth and survival

Interrogating metabolic crosstalk in the tumour-bone microenvironment, new research from the Edwards group shows how the pentose phosphate pathway contributes to prostate cancer bone metastasis.

Kassim Javaid awarded new funding for pioneering osteoporosis research

Kassim Javaid has been announced as one the successful applicants of The Royal Osteoporosis Society’s largest ever research grants round.

The Duchess of Cornwall opens the new Marcela Botnar wing

A new building at the University of Oxford's Botnar Institute for Musculoskeletal Sciences has been opened by The Duchess of Cornwall.

More effective treatment found for patients hospitalised with COVID-19 pneumonia

A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.